Skip to main content

Telemedicine May Help Folks Battling Opioid Addiction Stick With Treatment

By Dennis Thompson HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on July 18, 2024.

via HealthDay

THURSDAY, July 28, 2024 -- Telemedicine could be a better way to get opioid addicts to seek out and stick with treatment, a new study suggests.

People referred to an addiction treatment clinic following a telemedicine evaluation were more likely to show up to their first appointment than those whose referral resulted from an ER visit, researchers reported recently in the Journal of Substance Use and Addiction Treatment.

Those referred to addiction treatment through telemedicine also were more likely to stick with the program for at least a month.

“Our study shows that patients referred from telemedicine are more likely to follow up initially, and still be retained in care at 30 days,” said lead researcher Dr. Joshua Lynch, an associate professor of emergency medicine at the University of Buffalo in New York.

Long-term recovery from addiction requires consistent care, involving repeated outpatient visits as well as continuing use of treatment drugs like buprenorphine or methadone, researchers said.

“Patients with opioid use disorder often seek care in times of crisis in emergency departments,” said senior researcher Dr. Brian Clemency, a professor of emergency medicine at the University of Buffalo. “However, the emergency department may not be a good option for all patients. We wanted to see if telemedicine could be used as a gateway to ongoing care.”

For the study, researchers analyzed data on nearly 400 patients referred to addiction treatment between October 2020 and September 2022 through a network affiliated with the University of Buffalo.

Abut 65% of people referred through a telemedicine call showed up at their first clinic appointment, compared with just 32% of those referred through an ER visit, results showed.

Further, 53% of telemedicine patients were still in treatment after 30 days, versus 22% of those referred from an ER, researchers said.

It could be that doctors and nurses manning telemedicine services have better and more specific training at dealing with opioid addiction, the researchers said.

“Trying to educate hundreds of emergency department providers on the approach to opioid use disorder, evaluation, initiating medication and linking to treatment is very challenging,” said researcher Dr. Renoj Varughese, an assistant professor of emergency medicine at the University of Buffalo. “Emergency departments may have varying approaches and varying levels of interest in how they treat these patients.”

Telemedicine might also be a better option because it allows addicts to seek help promptly and privately, researchers added.

“Telemedicine allows us to provide care with minimal stigma, from the patient’s own home, with minimal waiting,” Lynch said in a university news release. “It gives us the ability to take some time and truly deliver effective one-on-one care.”

Sources

  • University of Buffalo, news release, July 15, 2024

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

First Malaria Drug Approved for Newborns and Small Babies, Coartem Baby

WEDNESDAY, July 9, 2025 — A new malaria treatment has been approved for newborns and infants under 11 pounds, filling a major gap in care for some of the most vulnerable...

Insured? You're More Likely To Survive Cancer Through Immunotherapy Treatment

WEDNESDAY, July 9, 2025 — Powerful new immunotherapies are offering fresh hope for patients with many different types of cancer. Unfortunately, that hope doesn’t...

American Academy of Pediatrics Sues HHS Over Vaccine Policy

TUESDAY, July 8, 2025 -- The American Academy of Pediatrics is suing the U.S. Department of Health and Human Services because of its recent decisions regarding vaccines for...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.